Gustavo A. Rosario Benitez

Array ( [id] => 9817194 [patent_doc_number] => 08926976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-06 [patent_title] => 'Modulators' [patent_app_type] => utility [patent_app_number] => 12/890598 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 63 [patent_no_of_words] => 80502 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12890598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11805197 [patent_doc_number] => 09546210 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-17 [patent_title] => 'Cripto antagonism of activin and TGF-b signaling' [patent_app_type] => utility [patent_app_number] => 12/887272 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 13755 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12887272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095295 [patent_doc_number] => 20110002928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Uses of Mammalian Cytokine; Related Reagents' [patent_app_type] => utility [patent_app_number] => 12/884493 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9556 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002928.pdf [firstpage_image] =>[orig_patent_app_number] => 12884493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007053 [patent_doc_number] => 20110059084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'AGENT FOR TREATING DISEASE' [patent_app_type] => utility [patent_app_number] => 12/880837 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 17405 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059084.pdf [firstpage_image] =>[orig_patent_app_number] => 12880837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007052 [patent_doc_number] => 20110059083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'AGENT FOR TREATING DISEASE' [patent_app_type] => utility [patent_app_number] => 12/880768 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 20203 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059083.pdf [firstpage_image] =>[orig_patent_app_number] => 12880768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007051 [patent_doc_number] => 20110059082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'AGENT FOR TREATING DISEASE' [patent_app_type] => utility [patent_app_number] => 12/880623 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 18949 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059082.pdf [firstpage_image] =>[orig_patent_app_number] => 12880623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10566317 [patent_doc_number] => 09289469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Depleting immunosuppressive monocytes within a mammal' [patent_app_type] => utility [patent_app_number] => 13/394787 [patent_app_country] => US [patent_app_date] => 2010-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3898 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943509 [patent_doc_number] => 20110104129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/870941 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 20947 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104129.pdf [firstpage_image] =>[orig_patent_app_number] => 12870941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608390 [patent_doc_number] => 07993645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Human anti-IL-23 antibodies, compositions, methods and uses' [patent_app_type] => utility [patent_app_number] => 12/855354 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 39354 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993645.pdf [firstpage_image] =>[orig_patent_app_number] => 12855354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125391 [patent_doc_number] => 20110086026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'ANTIBODIES AGAINST IL-13 RECEPTOR ALPHA 1 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/843225 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16248 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086026.pdf [firstpage_image] =>[orig_patent_app_number] => 12843225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070129 [patent_doc_number] => 20110044979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'DOMAIN ANTIBODY CONSTRUCT' [patent_app_type] => utility [patent_app_number] => 12/831874 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13101 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044979.pdf [firstpage_image] =>[orig_patent_app_number] => 12831874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6380306 [patent_doc_number] => 20100316650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'SOLUBLE MIC POLYPEPTIDES AS MARKERS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER AND AUTOIMMUNE DISEASES OR CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/830123 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 31339 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316650.pdf [firstpage_image] =>[orig_patent_app_number] => 12830123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8293972 [patent_doc_number] => 08221755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1)' [patent_app_type] => utility [patent_app_number] => 12/828589 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 12858 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12828589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10014043 [patent_doc_number] => 09057054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-16 [patent_title] => 'Antigen-specific long-term memory T-cells' [patent_app_type] => utility [patent_app_number] => 13/379075 [patent_app_country] => US [patent_app_date] => 2010-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17374 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375980 [patent_doc_number] => 08680245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'IL-13 binding protein' [patent_app_type] => utility [patent_app_number] => 13/321982 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 29561 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392051 [patent_doc_number] => 20100303821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'IMMUNOGLOBULINS' [patent_app_type] => utility [patent_app_number] => 12/787588 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 27391 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303821.pdf [firstpage_image] =>[orig_patent_app_number] => 12787588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13235075 [patent_doc_number] => 10130721 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-20 [patent_title] => Bifunctional polypeptides [patent_app_type] => utility [patent_app_number] => 13/319597 [patent_app_country] => US [patent_app_date] => 2010-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 8788 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110121 [patent_doc_number] => 20110189141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'MULTIPLE TARGET T CELL RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/783460 [patent_app_country] => US [patent_app_date] => 2010-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7836 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189141.pdf [firstpage_image] =>[orig_patent_app_number] => 12783460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262642 [patent_doc_number] => 20100297123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'COMBINATION THERAPY TO INHIBIT T CELL EFFECTOR FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/781709 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15951 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297123.pdf [firstpage_image] =>[orig_patent_app_number] => 12781709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477176 [patent_doc_number] => 20100285035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1' [patent_app_type] => utility [patent_app_number] => 12/774966 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 28349 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285035.pdf [firstpage_image] =>[orig_patent_app_number] => 12774966 [rel_patent_id] =>[rel_patent_doc_number] =>)